Erratum: VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast Cancer

S Sara A. Hurvitz (Department of Medicine, University of Washington Medicine, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle) R Rachel M. Layman (Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA) G Giuseppe Curigliano F Fabrice André M Massimo Cristofanilli (Weill-Cornell Medicine, New York–Presbyterian Hospital, New York) S Sung-Bae Kim (Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea) J Jorge Luis Martinez Rodriguez (Filios Alta Medicina, Monterrey, Mexico) J Jorge C. Nadal G Gun Min Kim L Louisa Lo Y Yuly A. Remolina-Bonilla G Geronimo Rosselli G George Emile E Ernesto Korbenfeld (British Hospital of Buenos Aires, Central British Hospital, Buenos Aires) J Juan Manuel Puig R Robert Wesolowski M Miguel Martín A Alistair Ring H Hyo S. Han A Antonio Giordano S Sarah C. Mutka K Keren Moss (1Dexoligo Therapeutics, Or Akiva, Israel) S Sam Suzuki B Brian Sullivan (Arcturus Therapeutics) I Igor Gorbatchevsky B Barbara Pistilli (Department of Cancer Medicine, Gustave Roussy, Villejuif, France)